AeroLeads people directory · profile

Keith Vendola, Md, Mba Email & Phone Number

Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All at Wugen
Location: San Francisco, California, United States 13 work roles 5 schools
1 work email found @iobiotech.com 1 phone found area 650 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email k****@iobiotech.com
Direct phone (650) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All
Location
San Francisco, California, United States

Who is Keith Vendola, Md, Mba? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Keith Vendola, Md, Mba is listed as Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All at Wugen, based in San Francisco, California, United States. AeroLeads shows a work email signal at iobiotech.com, phone signal with area code 650, and a matched LinkedIn profile for Keith Vendola, Md, Mba.

Keith Vendola, Md, Mba previously worked as Chief Financial Officer at Wugen and Chief Financial Officer at Io Biotech. Keith Vendola, Md, Mba holds Mba, Finance from Northwestern University - Kellogg School Of Management.

Company email context

Email format at Wugen

This section adds company-level context without repeating Keith Vendola, Md, Mba's masked contact details.

*@iobiotech.com
68% confidence

AeroLeads found 1 current-domain work email signal for Keith Vendola, Md, Mba. Compare company email patterns before reaching out.

Profile bio

About Keith Vendola, Md, Mba

Summary: As a seasoned biotech CFO with >3 decades experience in healthcare corporate finance including foundations from psychology, medical and business schools, research labs, and Wall Street, Dr. Vendola focuses on building teams and life sciences companies whose missions aim to improve both patient outcomes and investor returns. Passions:Dr. Vendola enjoys leading strong teams, scaling operations, and navigating all types of transactions, including IPOs, financings, and strategic deals, while thoughtfully interacting with physicians, scientists, patients, academics, executives, consultants, accountants, bankers, lawyers, investors, and other stakeholders.Background:Dr. Vendola has served as a Silicon Valley-based public and private company Chief Financial Officer (CFO), Chief Strategy Officer (CSO), Adviser, and Executive and NYC-based bulge bracket Investment Banker (BofA, JPMorgan). Dr. Vendola earned his MBA in Finance from Northwestern’s Kellogg School of Management, MD from Dartmouth Medical School, Research Fellowship in Endocrinology from the NIH, where he authored several papers, and BA in Psychology from Holy Cross, where he graduated with honors.Skills:* Solid network across top investment banks, law firms, accountancies, and funds. * Investor relations and corporate communications. * Strategic leadership including >50 deals across the globe.* Operational planning and execution.* Team building driven by a firm belief in the excellence of others, value of camaraderie, and potential of partnership.Accomplishments:> 500 live investor meetings & multiple presentations.> $2B in successfully executed transactions.> $1B raised capital via IPOs, FPOs, PIPEs, etc. Equity / debt, private / public. > $1B transaction value via M&A, partnerships, and special situations. > $400M managed as CFO across public and private P&Ls.Personal:Avid downhill skier. Adoring husband. Proud father of 3.

Listed skills include Mergers And Acquisitions, Strategy, Business Development, Corporate Development, and 41 others.

Current workplace

Keith Vendola, Md, Mba's current company

Company context helps verify the profile and gives searchers a useful next step.

Wugen
Wugen
Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All
AeroLeads page
13 roles · 28 years

Keith Vendola, Md, Mba work experience

A career timeline built from the work history available for this profile.

Chief Financial Officer

Current

St. Louis, Missouri, Us

Wugen is a clinical-stage private biotech and an industry leader in off-the-shelf allogeneic cell therapies. Backed by top investors, we are developing a CD7 directed CAR-T cell therapy. With promising clinical data, the late stage program addresses a large unmet need in T-ALL/LBL and other indications. As CFO, focus is on strategically growing the business, interacting thoughtfully with investors and other stakeholders, and leading a strong finance team.

2023 - Present ~3 yrs 6 mos

Chief Financial Officer

Copenhagen, Denmark, Dk

IPOCompany successfully taken public on Nasdaq (IOBT). Peak Mrk Cap while there >$400M. Raised ~$200M. Clinical-stage biotech: immuno-oncology. Launched onto Nasdaq, navigated public markets, scaled team, and executed deals while overseeing FP&A, accounting, treasury, IT, investor relations, corporate communications, etc. Responsibilities: Transactions, Financial Operations, IR and Corp. Comms.* Led $115M IPO & Nasdaq listing (Morgan Stanley, Cowen, Jefferies).* Raised $84M private / crossover round.* Closed 2 Merck collaborations providing pembrolizumab for Ph 3 and Ph 2 trials.* Built and led international teams across FP&A, accounting, treasury, IT, etc.

2021 - 2022 ~1 yr

Co-Founder And Board Member

Rezolute (Bio) Ireland Limited
2019 - 2021 ~2 yrs

Chief Financial Officer & Chief Strategy Officer

Redwood City, California, Us

Uplisting w/ PIPECompany successfully taken public on Nasdaq (RZLT). Peak Mrk Cap >$300M. Raised >$100M. Clinical-stage biotech: orphan and metabolic. Launched onto Nasdaq, navigated public markets, scaled team, and executed deals while overseeing FP&A, accounting, treasury, IT, investor relations, corporate communications, etc. Responsibilities: Financial Operations, Transactions, IR and Corp. Comms.* Led $41M PIPE (Federated, BVF) & Nasdaq listing (CG, JMP, Griffin).* Raised $49M strategic financing (CG, JMP).* Led $50M ATM (Opco), $200M Shelf, and $30M venture debt.* Drove partnership with Xoma.

2018 - 2021 ~3 yrs

Chief Of Staff To Ceo & Vp Of Investor Relations

Redwood City, Ca, Us

IPOCompany successfully taken public on Nasdaq (CHRS). Peak Mrk Cap while there >$1B. Raised $300M. Commercial-stage biotech / medtech: biosimilars and oncology. Navigated public markets, scaled team, led competitive strategy, and executed deals. Responsibilities: Strategy, Transactions, Special Situations, IR, and Corp. Comms.* Led $100M private placement, sr. convert. notes (HCRP, KKR).* Drove $72M FPO (Barclays underwritten).* Raised $128M FPO (JPMorgan, Citi, Cowen, BMO).

2015 - 2017 ~2 yrs

Management Consultant, Healthcare Strategy

Worked with boards and senior executives on strategy, execution, and M&A across healthcare verticals.* Advised large cap pharma (top line >$15B) on strategic direction for flagship asset (>$10B in sales).* Advised public biotech / med tech on go / no-go decision for international JV.* Advised health plan on successful $1.2B acquisition of managed care co.* Advised hospital system with >$10B in revenue on productivity initiatives.

2013 - 2014 ~1 yr

Sabbatical

Family

Full-time husband and father. Recreational downhill skier.

2012 - 2012

Co-Founder And Financial Officer, Vp Of Finance & Corporate Development

Eiger Biopharmaceuticals

Reverse merger w/ private roundCompany successfully taken public on Nasdaq (EIGR). Peak Mrk Cap >$400M. Commercial-stage biotech: orphan and infective. Launched company, scaled team, led financial operations, and executed deals. Responsibilities: Financial Operations and Transactions.* Company formation & Stanford spin-out.* Raised venture financings from Sand Hill Rd.* Acquired PC & clinical assets from Stanford, AstraZeneca, and Merck.

2009 - 2011 ~2 yrs

Head Of Corporate Development

Diobex

Clinical-stage biotech / medtech: metabolic.

2007 - 2009 ~2 yrs

Head Of Business Development

Threshold Pharmaceuticals

IPO and then mergerCompany successfully taken public on Nasdaq (THLD) and later merged into Molecular Templates (MTEM). Peak Mrk Cap while there >$500M. Raised >$100M. Clinical-stage biotech: urology and oncology. Led WW partnering for late stage pipeline. Sourced and managed relationships across pharma and biotech. Executed M&A. Supported financings. Key spokesman at numerous conferences WW.* $37M IPO & Nasdaq listing (BofA, CIBC, Lazard, WB).* $65M FPO (Morgan Stanley, CIBC, Lazard).* Development partnership in Asia.

2004 - 2007 ~3 yrs

Investment Banker, Healthcare

Charlotte, Nc, Us

Advised on M&A and executed financings that raised ~$450M across healthcare verticals. * $115M IPO and Nasdaq listing for ViaCell, S-1 filed Jan. 2002.* $28M PIPE for Regeneration Technologies.* $115M senior notes offering for Bausch & Lomb.* $125M convertible senior debentures offering for Edwards Lifesciences.* $115M convertible senior debentures offering for Sierra Health Services.* $65M revolving credit facility for Sierra Health Services.

2001 - 2003 ~2 yrs

Commercial / Marketing

Basel, Baselstadt, Ch

1999 - 1999
5 education records

Keith Vendola, Md, Mba education

Mba, Finance

Northwestern University - Kellogg School Of Management

Md, Medicine

Geisel School Of Medicine At Dartmouth

Executive Certificate, Negotiations

Harvard Business School

Research Fellowship, Scientist, Endocrinology

National Institutes Of Health

Ba, Psychology / Pre-Med

College Of The Holy Cross
FAQ

Frequently asked questions about Keith Vendola, Md, Mba

Quick answers generated from the profile data available on this page.

What company does Keith Vendola, Md, Mba work for?

Keith Vendola, Md, Mba works for Wugen.

What is Keith Vendola, Md, Mba's role at Wugen?

Keith Vendola, Md, Mba is listed as Biotech CFO - Passionate about the Life Sciences, Building Innovative Companies, & Improving Healthcare for Us All at Wugen.

What is Keith Vendola, Md, Mba's email address?

AeroLeads has found 1 work email signal at @iobiotech.com for Keith Vendola, Md, Mba at Wugen.

What is Keith Vendola, Md, Mba's phone number?

AeroLeads has found 1 phone signal(s) with area code 650 for Keith Vendola, Md, Mba at Wugen.

Where is Keith Vendola, Md, Mba based?

Keith Vendola, Md, Mba is based in San Francisco, California, United States while working with Wugen.

What companies has Keith Vendola, Md, Mba worked for?

Keith Vendola, Md, Mba has worked for Wugen, Io Biotech, Rezolute (Bio) Ireland Limited, Rezolute, Inc., and Coherus Biosciences.

How can I contact Keith Vendola, Md, Mba?

You can use AeroLeads to view verified contact signals for Keith Vendola, Md, Mba at Wugen, including work email, phone, and LinkedIn data when available.

What schools did Keith Vendola, Md, Mba attend?

Keith Vendola, Md, Mba holds Mba, Finance from Northwestern University - Kellogg School Of Management.

What skills is Keith Vendola, Md, Mba known for?

Keith Vendola, Md, Mba is listed with skills including Mergers And Acquisitions, Strategy, Business Development, Corporate Development, Start Ups, Strategic Planning, Venture Capital, and Finance.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.